Orthopedic growth slowed in Europe following an economic downturn, but it appears to finally be catching up to the U.K.-based S&N. In the third quarter, the company experienced hip and knee growth both at home and globally.
S&N is also looking to expand outside of hips and knees; its wound-care sales are forecasted to be about 30 percent of its total. Recent partnerships in Brazil and Turkey may also help propel the company in the next five years.
More Articles on Devices:
Boston Scientific’s Spinal Cord Stimulator System Results in Significant Pain Reduction, Study Finds
Blue M Medical to Launch Operations in Indiana
Osseon Therapeutics Appoints Gary Hogman Regional Sales Director
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
